【24h】

Erenumab-aooe

机译:Erenumab-Face

获取原文
获取原文并翻译 | 示例
           

摘要

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly I-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.
机译:每个月,订阅者对正式专着的服务收到5至6名关于新发布的药物或在第3期试验中的药物上的良好文件专着。 专着针对药房和治疗委员会的目标。 订阅者还收到每月I页的摘要专着,这些专着对议程和药房/护理中有用的代理商。 每月还提供综合目标药物利用评估/药物使用评估(逾期/ mue)。 通过订阅,专着在线提供给订阅者。 可以定制专着以满足设施的需求。 通过惯例,医院药房在本专栏中发表选定的审查。 有关制定公式服务的更多信息,请在866-397-3433联系Wolters Kluwer客户服务。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号